sulfur hexafluoride has been researched along with Hemorrhage, Retinal in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (7.25) | 18.2507 |
| 2000's | 35 (50.72) | 29.6817 |
| 2010's | 27 (39.13) | 24.3611 |
| 2020's | 2 (2.90) | 2.80 |
| Authors | Studies |
|---|---|
| Guerriero, M; Maggio, E; Mete, M; Peroglio Deiro, A; Pertile, G; Polito, A; Prigione, G; Sartore, M | 1 |
| Agarwal, A; Aggarwal, K; Gupta, V; Handa, S; Markan, A | 1 |
| Lapere, SRJ; Plemel, DJA; Rudnisky, CJ; Tennant, MTS | 1 |
| Arslan, G; Bardak, H; Bardak, Y; Erçalık, Y; Erdem, B; Timlioglu, S | 1 |
| Hirano, Y; Kato, A; Kimura, M; Ogura, Y; Shibata, Y; Uemura, A; Yasukawa, T; Yoshida, M | 1 |
| Regillo, CD; Shields, RA; Silva, RA; Tang, PH | 1 |
| Mahmoud, TH; Martel, JN | 1 |
| Chang, W; Garg, SJ; Gupta, SA; Ho, AC; Hsu, J; Maturi, R; Regillo, CD; Sivalingam, A | 1 |
| Goldman, DR; Reichel, E; Vora, RA | 1 |
| Cho, HJ; Han, JI; Kim, HS; Kim, JH; Kim, JW; Koh, KM; Lee, TG; Lew, YJ | 1 |
| Hirakata, A; Inoue, M; Kimura, S; Morizane, Y; Shiraga, F; Shirakata, Y | 1 |
| Byeon, SH; Lee, JM; Shin, JY | 1 |
| Ehlers, JP; Petkovsek, DS; Singh, RP; Srivastava, SK; Yuan, A | 1 |
| Stoffelns, BM | 1 |
| Bijl, HM; Buschini, E; Iannetta, D; Lesnik Oberstein, SY; Mura, M | 1 |
| Araújo, J; Carneiro, Â; Falcão-Reis, F; Faria, PA; Rocha-Sousa, A; Sousa, C | 1 |
| Byeon, SH; Choi, HJ; Choi, M; Chung, B; Lee, J; Shin, JY | 1 |
| Barr, CC; Fassbender, JM; Schaal, S; Sherman, MP | 1 |
| Karska-Basta, I; Kubicka-Trząska, A; Miniewicz, J; Romanowska-Dixon, B | 1 |
| Abboud, M; Benzerroug, M; Milazzo, S | 1 |
| Hirano, Y; Ogura, Y; Sato, R; Yasukawa, T | 1 |
| Hattenbach, LO; Höhn, F; Mirshahi, A | 1 |
| Framme, C; Gabel, VP; Hillenkamp, J; Sachs, HG; Surguch, V | 1 |
| Auriol, S; Lequeux, L; Mahieu, L; Pagot-Mathis, V; Quintyn, JC | 1 |
| Beckford-Torngren, C; Benítez-Herreros, J; Cámara-González, C; Castro-Rebollo, M; Gros-Otero, J | 1 |
| Tsymanava, A; Uhlig, CE | 1 |
| Chandrakumar, HV; Ganesh, S; Joshi, GR; Sampangi, R; Somashekar, SE | 1 |
| Hirano, Y; Ito, Y; Mizutani, T; Ogura, Y; Takase, A; Yasukawa, T; Yoshida, M | 1 |
| Gandorfer, A; Hakim, I; Haritoglou, C; Kampik, A; Mayer, WJ; Ulbig, M; Wolf, A | 1 |
| Cereda, MG; van Meurs, JC; van Zeeburg, EJ | 1 |
| Brieden, M; Gümbel, H; Hattenbach, LO; Koch, F | 1 |
| Hesse, L; Schulze, SD | 1 |
| Borrillo, JL; Regillo, CD; Tennant, MT | 1 |
| Marek, J; Nizankowska, MH; Oficjalska-Młyńczak, J; Zajac-Pytrus, H | 1 |
| Bornfeld, N; Foerster, MH; Gabel-Pfisterer, A; Heimann, H; Jandeck, C; Kellner, U; Laue, J | 1 |
| Hoffmann, EM; Schwenn, O | 1 |
| Buttery, R; Polkinghorne, PJ; Vote, BJ | 1 |
| Kittantong, A; Ratanasukon, M | 1 |
| Heinzl, H; Mozaffarieh, M; Sacu, S; Wedrich, A | 1 |
| Axer-Siegel, R; Ehrlich, R; Ron, Y; Rosenblatt, I; Weinberger, D | 1 |
| Chamberlain, M; Chen, CY; Chiu, D; Heriot, WJ; Hooper, C; Karia, N | 1 |
| Lincoff, A; Lincoff, H; Stopa, M | 1 |
| García-Gómez, PJ; García-Layana, A; Heras-Mulero, H; Sádaba-Echarri, LM; Salinas-Alamán, A | 1 |
| Chen, MS; Fang, IM; Lin, YC; Yang, CH; Yang, CM | 1 |
| Eter, N; Helb, HM; Holz, FG; Meyer, CH; Scholl, HP | 1 |
| Bando, H; Emi, K; Ikeda, T; Kashimoto, D; Matsumura, N; Morita, S; Okita, T; Oyagi, T; Sawada, K; Toyoda, E; Ueno, C | 1 |
| Grossniklaus, HE; Matsuo, T; Ohtsuki, H; Okanouchi, T; Shiraga, F; Takasu, I; Yokoe, S | 1 |
| Blodi, BA; Elner, SG; Hassan, AS; Johnson, MW; Poliner, LS; Regillo, CD; Schneiderman, TE; Tornambe, PE | 1 |
| Jochmann, C; Meier, P; Wiedemann, P; Zeumer, C | 1 |
| Buhl, M; Kampik, A; Scheider, A; Schönfeld, CL | 1 |
| Daneshvar, H; Kertes, PJ; Leonard, BC; Peyman, GA | 1 |
| Framme, C; Gabel, VP; Lohmann, CP; Roider, J; Sachs, HG; Spiegel, D; Toukhy, HE | 1 |
| Chen, MS; Yang, CM | 1 |
| Kokame, GT | 1 |
| Krepler, K; Kruger, A; Stur, M; Tittl, M; Wedrich, A | 1 |
| Lommatzsch, PK | 1 |
| Heller, G; Hesse, L; Kroll, P; Schroeder, B | 1 |
| Averbukh, E; Berger, AR; Devenyi, RG; Lam, WC | 1 |
| Hesse, L; Kroll, P | 1 |
| Hay, SR; Madonna, RJ | 1 |
| Amemiya, T; Kitaoka, T; Mera, A; Ogawa, T; Saitoh, AK | 1 |
| Behrens-Bauman, W; Hitzer, S; Kreutzer, B; Schmitz, K | 1 |
| Cox, TA; Fekrat, S; Haupert, CL; Jaffe, GJ; McCuen, BW; Postel, EA; Steuer, ER; Toth, CA | 1 |
| Gümbel, HO; Hattenbach, LO; Klais, C; Koch, FH | 1 |
| Matsuo, T; Shiraga, F; Takasu, I | 1 |
| Chen, SN; Ho, CL; Ho, JD; Kuo, YH | 1 |
| Kinoshita, S; Koizumi, K; Yamasaki, T; Yasuhara, T | 1 |
| Koziorowska, M; Nizankowska, MH; Popiela, G; Zajac-Pytrus, H | 1 |
| Lewis, H | 1 |
1 review(s) available for sulfur hexafluoride and Hemorrhage, Retinal
| Article | Year |
|---|---|
Management of submacular hemorrhage.
Topics: Fibrinolytic Agents; Fluorocarbons; Humans; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy | 2002 |
4 trial(s) available for sulfur hexafluoride and Hemorrhage, Retinal
| Article | Year |
|---|---|
Flattening of retinal pigment epithelial detachments after pneumatic displacement of submacular hemorrhages secondary to age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Endotamponade; Female; Fibrinolytic Agents; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Intravitreal Injections; Male; Middle Aged; Retinal Detachment; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2018 |
[Combined intravitreal injection of bevacizumab and SF6 gas for treatment of submacular hemorrhage secondary to age-related macular degeneration].
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Female; Humans; Injections; Macula Lutea; Macular Degeneration; Male; Retinal Hemorrhage; Sulfur Hexafluoride; Treatment Outcome; Vitreous Body | 2010 |
Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aneurysm; Eye Injuries; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Macula Lutea; Macular Degeneration; Male; Middle Aged; Postoperative Complications; Prone Position; Retinal Hemorrhage; Retinal Vessels; Retrospective Studies; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 1999 |
Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Pilot Projects; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2000 |
64 other study(ies) available for sulfur hexafluoride and Hemorrhage, Retinal
| Article | Year |
|---|---|
Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Fluorescein Angiography; Humans; Intravitreal Injections; Male; Middle Aged; Prone Position; Recombinant Proteins; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Vitrectomy; Wet Macular Degeneration | 2020 |
Subretinal Hemorrhage Complicating Retinal Angiomatous Proliferation in Tubercular Retinal Vasculitis.
Topics: Adult; Cell Proliferation; Fibrinolytic Agents; Fluorescein Angiography; Humans; Macular Degeneration; Male; Retinal Hemorrhage; Retinal Vasculitis; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy | 2022 |
VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR AND GAS TAMPONADE FOR SUBFOVEAL HEMORRHAGE: Prognostic Factors and Clinical Outcomes.
Topics: Adult; Aged; Aged, 80 and over; Endotamponade; Female; Fibrinolytic Agents; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Injections, Intraocular; Male; Middle Aged; Prognosis; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Time Factors; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Vitrectomy; Young Adult | 2019 |
Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Fluorescein Angiography; Humans; Intravitreal Injections; Male; Middle Aged; Pilot Projects; Prone Position; Ranibizumab; Retina; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2018 |
Displacement of Submacular Hemorrhage With Subretinal Injection of Recombinant Tissue Plasminogen Activator and Gas Tamponade in the Setting of Myopic Degeneration.
Topics: Adolescent; Bruch Membrane; Endotamponade; Fibrinolytic Agents; Fluorescein Angiography; Fundus Oculi; Humans; Injections, Intraocular; Male; Myopia, Degenerative; Refraction, Ocular; Retinal Hemorrhage; Retinal Pigment Epithelium; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitrectomy | 2019 |
Subretinal pneumatic displacement of subretinal hemorrhage.
Topics: Air Pressure; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Endotamponade; Fibrinolytic Agents; Humans; Photography; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Tomography, Optical Coherence; Vitrectomy | 2013 |
Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Air; Angiogenesis Inhibitors; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Humans; Injections, Intraocular; Male; Middle Aged; Prone Position; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Wet Macular Degeneration | 2014 |
Traumatic choroidal rupture with submacular hemorrhage treated with pneumatic displacement.
Topics: Adult; Air Pressure; Choroid; Eye Injuries; Female; Humans; Retinal Hemorrhage; Rupture; Sulfur Hexafluoride; Treatment Outcome; Wounds, Nonpenetrating | 2014 |
Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Coloring Agents; Combined Modality Therapy; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.
Topics: Aged; Aged, 80 and over; Aneurysm, Ruptured; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Humans; Injections, Intraocular; Male; Middle Aged; Prone Position; Retinal Artery; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Vitrectomy | 2015 |
Anti-vascular endothelial growth factor with or without pneumatic displacement for submacular hemorrhage.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Humans; Intravitreal Injections; Male; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
Intrasurgical assessment of subretinal tPA injection for submacular hemorrhage in the PIONEER study utilizing intraoperative OCT.
Topics: Aged; Aged, 80 and over; Endotamponade; Female; Fibrinolytic Agents; Humans; Injections, Intraocular; Male; Middle Aged; Monitoring, Intraoperative; Posture; Prospective Studies; Retinal Hemorrhage; Sulfur Hexafluoride; Surgery, Computer-Assisted; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Vitrectomy | 2015 |
[Findings of Optical Coherence Tomography (OCT) in Submacular Haemorrhage Displacement Due to a Retinal Macroaneurysm by Intravitreal Injection of Gas and Recombinant Tissue Plasminogen Activator (rtPA)].
Topics: Aneurysm; Drug Therapy, Combination; Endotamponade; Humans; Macula Lutea; Male; Middle Aged; Recombinant Proteins; Retinal Artery; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Tomography, Optical Coherence; Treatment Outcome | 2015 |
Subretinal versus intravitreal injection of recombinant tissue plasminogen activator in post-traumatic submacular haemorrhages.
Topics: Endotamponade; Eye Injuries; Fibrinolytic Agents; Humans; Injections, Intraocular; Intravitreal Injections; Male; Recombinant Proteins; Retina; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Vitrectomy; Wounds, Nonpenetrating | 2016 |
Intravitreal injection of recombinant tissue plasminogen activator in submacular hemorrhage: case series.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Endotamponade; Eye Injuries; Female; Fibrinolytic Agents; Humans; Intravitreal Injections; Male; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Wet Macular Degeneration; Wounds, Nonpenetrating | 2016 |
Anti-Vascular Endothelial Growth Factor with Gas for Submacular Hemorrhage.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Combined Modality Therapy; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
Topics: Aged; Aged, 80 and over; Endotamponade; Exudates and Transudates; Female; Fibrinolytic Agents; Fluorocarbons; Fovea Centralis; Humans; Intravitreal Injections; Male; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tertiary Care Centers; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Vitrectomy; Wet Macular Degeneration | 2016 |
[Managment of subretinal heamorrhages within the macular area using intravitreal injections of recombined tissue plasminogen activator, sulphur hexafluoride and ranihizumab--preliminary report].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Intravitreal Injections; Macula Lutea; Macular Degeneration; Middle Aged; Ranibizumab; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2015 |
[Treatment of macular hematoma complicating AMD by vitrectomy, subretinal r-TPA injection, intravitreal injection of bevacizumab combined with gas tamponade: Report of 4 cases].
Topics: Aged; Aged, 80 and over; Bevacizumab; Female; Hematoma; Humans; Intravitreal Injections; Macular Degeneration; Male; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy | 2017 |
Early-onset macular holes following ruptured retinal arterial macroaneurysms.
Topics: Aged; Aged, 80 and over; Aneurysm, Ruptured; Epiretinal Membrane; Female; Humans; Macula Lutea; Male; Retinal Artery; Retinal Detachment; Retinal Hemorrhage; Retinal Perforations; Sulfur Hexafluoride; Time Factors; Visual Acuity; Vitrectomy | 2008 |
Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
Topics: Aged; Combined Modality Therapy; Female; Fibrinolytic Agents; Fluorescein Angiography; Humans; Injections; Male; Recombinant Proteins; Retina; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitrectomy; Vitreous Body | 2010 |
[Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Female; Fibrinolytic Agents; Fluorescein Angiography; France; Hematoma; Humans; Injections, Intraocular; Macular Degeneration; Male; Photochemotherapy; Prognosis; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitrectomy | 2010 |
[Management of subretinal hemorrhage with r-TPA, SF-6 and ranibizumab].
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Humans; Injections, Intraocular; Macular Degeneration; Male; Paracentesis; Ranibizumab; Recombinant Proteins; Recurrence; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitreous Body | 2010 |
Intravitreal recombinant tissue plasminogen activator without and with additional gas injection in patients with submacular haemorrhage associated with age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Fluorocarbons; Gases; Humans; Intraocular Pressure; Intraoperative Complications; Intravitreal Injections; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Wet Macular Degeneration | 2012 |
SD-OCT to differentiate traumatic submacular hemorrhage types using automatic three-dimensional segmentation analysis.
Topics: Adolescent; Adult; Choroid; Eye Injuries; Humans; Imaging, Three-Dimensional; Male; Prone Position; Retinal Hemorrhage; Retinal Pigment Epithelium; Rupture; Sulfur Hexafluoride; Tennis; Tomography, Optical Coherence; Visual Acuity; Wounds, Nonpenetrating | 2011 |
Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.
Topics: Aged; Aged, 80 and over; Aneurysm, Ruptured; Angiogenesis Inhibitors; Combined Modality Therapy; Fibrinolytic Agents; Follow-Up Studies; Humans; Intravitreal Injections; Macula Lutea; Macular Degeneration; Middle Aged; Photochemotherapy; Prone Position; Recurrence; Retinal Artery; Retinal Diseases; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity | 2011 |
Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract Extraction; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Humans; Intravitreal Injections; Male; Pilot Projects; Recombinant Proteins; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Wet Macular Degeneration | 2013 |
Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm.
Topics: Aged; Aged, 80 and over; Aneurysm; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Humans; Laser Coagulation; Male; Middle Aged; Postoperative Complications; Posture; Recombinant Proteins; Retinal Hemorrhage; Retinal Vessels; Retrospective Studies; Sulfur Hexafluoride; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitrectomy | 2013 |
[Intravitreal injection of rt-PA and gas in the management of minor submacular haemorrhages secondary to age-related macular degeneration].
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Middle Aged; Ophthalmoscopy; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2002 |
Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Middle Aged; Prone Position; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitrectomy; Vitreous Body | 2002 |
[Treatment of subretinal macular hemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas].
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Injections; Macular Degeneration; Male; Middle Aged; Retinal Diseases; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity | 2003 |
Long-term results after surgical extraction of subfoveal choroidal neovascular membranes with and without haemorrhage in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Macular Degeneration; Male; Membranes; Middle Aged; Prognosis; Recurrence; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Visual Acuity; Vitrectomy | 2004 |
[Heterochromia of the Iris after t-PA and Gas Injection of Sulfur Fluoride].
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Follow-Up Studies; Fundus Oculi; Humans; Iridocyclitis; Macula Lutea; Pigment Epithelium of Eye; Postoperative Complications; Reoperation; Retinal Hemorrhage; Sulfur Hexafluoride; Vitrectomy; Vitreous Hemorrhage | 2004 |
Endophthalmitis after intravitreal injection of frozen preprepared tissue plasminogen activator (tPA) for pneumatic displacement of submacular hemorrhage.
Topics: Aged; Cryopreservation; Drug Contamination; Endophthalmitis; Eye Infections, Bacterial; Female; Fluorocarbons; Gram-Positive Bacterial Infections; Humans; Injections; Propionibacterium acnes; Retinal Hemorrhage; Streptococcus; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitreous Body | 2004 |
Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Fluorocarbons; Follow-Up Studies; Gases; Humans; Macular Degeneration; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Thailand; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity | 2005 |
In-patient management and treatment satisfaction after intravitreous plasminogen activator injection.
Topics: Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Injections; Inpatients; Macular Degeneration; Patient Satisfaction; Prone Position; Prospective Studies; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Surveys and Questionnaires; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2006 |
Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Pressure; Prone Position; Retinal Hemorrhage; Sulfur Hexafluoride; Time Factors; Visual Acuity | 2007 |
Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Intraoperative Complications; Male; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2007 |
Analysis of forces acting upon submacular hemorrhage in pneumatic displacement.
Topics: Fluorocarbons; Gravitation; Humans; Models, Biological; Pressure; Prone Position; Retinal Hemorrhage; Sulfur Hexafluoride | 2007 |
[Traumatic submacular hemorrhage treated with rt-PA and SF6].
Topics: Adult; Eye Injuries; Humans; Male; Retinal Hemorrhage; Sulfur Hexafluoride; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2007 |
Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Gases; Humans; Macular Degeneration; Male; Middle Aged; Prognosis; Recombinant Proteins; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2009 |
Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.
Topics: Acute Disease; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Female; Fibrinolytic Agents; Humans; Injections; Macular Degeneration; Male; Middle Aged; Pilot Projects; Prone Position; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2008 |
[Evaluation of the efficacy of intravitreal gas injection for submacular hemorrhages].
Topics: Aged; Aged, 80 and over; Female; Gases; Humans; Injections; Macula Lutea; Male; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Vitreous Body | 2008 |
Surgical treatment of submacular hemorrhage associated with idiopathic polypoidal choroidal vasculopathy.
Topics: Aged; Choroid; Choroid Diseases; Female; Fibrinolytic Agents; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Injections; Laser Coagulation; Macula Lutea; Male; Middle Aged; Postoperative Complications; Reoperation; Retina; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy; Vitreous Body | 1999 |
[Management of submacular hemorrhage by tissue plasminogen activator and SF(6) gas injection].
Topics: Aged; Electroretinography; Female; Fibrinolytic Agents; Fluorescein Angiography; Fundus Oculi; Humans; Injections; Laser Coagulation; Macular Degeneration; Male; Retinal Hemorrhage; Sulfur Hexafluoride; Time Factors; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 1999 |
[Intra-vitreal rt-PA and gas introduction in submacular hemorrhage].
Topics: Aged; Aged, 80 and over; Aneurysm; Choroidal Neovascularization; Female; Humans; Injections; Male; Recombinant Proteins; Retinal Degeneration; Retinal Hemorrhage; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Vitreous Body | 1999 |
Management of submacular hemorrhage with intravitreal sulfur hexafluoride: a pilot study.
Topics: Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Injections; Macula Lutea; Macular Degeneration; Pilot Projects; Prone Position; Retinal Hemorrhage; Sulfur Hexafluoride; Treatment Outcome; Visual Acuity; Vitreous Body | 1999 |
[Clinical results of intravitreal administration of tissue-type plasminogen activator (tPA) and gas for removal of subretinal hemorrhage in senile macular degeneration].
Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Female; Humans; Laser Coagulation; Macular Degeneration; Male; Middle Aged; Retinal Hemorrhage; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Vitreous Body | 2000 |
Tissue plasminogen activator and gas for diabetic premacular hemorrhage.
Topics: Adult; Diabetic Retinopathy; Fibrinolysis; Fibrinolytic Agents; Humans; Injections; Middle Aged; Prone Position; Retinal Hemorrhage; Retinal Neovascularization; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity | 2000 |
Vitreous hemorrhage after intravitreal tissue plasminogen activator (t-PA) and pneumatic displacement of submacular hemorrhage.
Topics: Aged; Aged, 80 and over; Aneurysm; Female; Fibrinolytic Agents; Humans; Injections; Macula Lutea; Male; Retinal Artery; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy; Vitreous Hemorrhage | 2000 |
[Comment on the contribution by P. Meier et al.: Submacular hemorrhage. Therapy with tissue plasminogen activator and SF6 gas].
Topics: Follow-Up Studies; Humans; Injections; Macula Lutea; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy | 2000 |
Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.
Topics: Acute Disease; Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Middle Aged; Retina; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2000 |
Pneumatic displacement of submacular hemorrhage.
Topics: Humans; Macula Lutea; Macular Degeneration; Plasminogen Activators; Retinal Hemorrhage; Retinal Vessels; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity | 2000 |
Pneumatic displacement of submacular hemorrhage.
Topics: Fibrinolytic Agents; Humans; Injections; Macula Lutea; Macular Degeneration; Retinal Hemorrhage; Retinal Vessels; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity | 2000 |
Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
Topics: Aged; Humans; Injections; Macular Degeneration; Male; Plasminogen Activators; Retina; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2000 |
Treatment for subretinal hemorrhage in the macula: pneumatic displacement of hemorrhages.
Topics: Acetazolamide; Aged; Aged, 80 and over; Female; Fundus Oculi; Humans; Injections; Intraocular Pressure; Macula Lutea; Mannitol; Middle Aged; Ocular Hypertension; Pressure; Prone Position; Retinal Hemorrhage; Sulfur Hexafluoride; Visual Acuity | 2000 |
Therapy of subhyaloidal hemorrhage by intravitreal application of rtPA and SF(6) gas.
Topics: Female; Humans; Intraocular Pressure; Light Coagulation; Middle Aged; Plasminogen Activators; Retinal Hemorrhage; Sulfur Hexafluoride; Treatment Outcome; Visual Acuity | 2000 |
Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Injections; Macular Degeneration; Male; Recurrence; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitrectomy | 2001 |
Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Injections; Macula Lutea; Macular Degeneration; Male; Middle Aged; Plasminogen Activators; Prone Position; Prospective Studies; Recombinant Proteins; Retinal Hemorrhage; Safety; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2001 |
Planned two-step vitrectomy for extremely large and thick subretinal hematoma.
Topics: Aged; Female; Fluorescein Angiography; Hematoma; Humans; Laser Coagulation; Male; Middle Aged; Prone Position; Retinal Hemorrhage; Sulfur Hexafluoride; Treatment Outcome; Visual Acuity; Vitrectomy | 2001 |
Intravitreous tissue plasminogen activator injection and pneumatic displacement in the management of submacular hemorrhage complicating scleral buckling procedures.
Topics: Adult; Aged; Female; Fibrinolytic Agents; Humans; Injections; Macula Lutea; Male; Middle Aged; Prone Position; Recombinant Proteins; Retinal Hemorrhage; Scleral Buckling; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body; Vitreous Hemorrhage | 2001 |
Spontaneous remodelling of retinal veins accidentally severed during vitreous surgery.
Topics: Collateral Circulation; Diathermy; Eye Injuries; Fluorescein Angiography; Follow-Up Studies; Humans; Intraocular Pressure; Intraoperative Complications; Male; Middle Aged; Retinal Hemorrhage; Retinal Vein; Sulfur Hexafluoride; Vitrectomy; Wound Healing | 2002 |
[Management in preretinal macular hemorrhage. Case report].
Topics: Eye Injuries; Female; Humans; Laser Therapy; Middle Aged; Plasminogen Activators; Retinal Hemorrhage; Sulfur Hexafluoride; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity | 2001 |
tPA and gas in submacular hemorrhage.
Topics: Fibrinolytic Agents; Humans; Injections; Macular Degeneration; Prognosis; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity | 2002 |